Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Exploring Venous Waveforms for Non-Invasive Respiratory Monitoring in Pigs
Published on: March 8, 2024
A Case of Reversible Infantile Respiratory Chain Deficiency Presenting With Hypotonia, Hyperammonemia, and Failure to
Jessenia C Guerrero1, Helio Pedro2, Sarah Parisotto2
1Department of Pathology, Immunology and Laboratory Medicine, Rutgers-New Jersey Medical School, Newark, New Jersey.
Insights
Reversible infantile respiratory chain deficiency, a rare mitochondrial disorder, can present with hyperammonemia. This condition, marked by muscle weakness, may resolve spontaneously in infants who survive early life.
Area of Science:
- Genetics
- Pediatrics
- Neurology
Background:
- Reversible infantile respiratory chain deficiency is a rare mitochondrial disorder.
- It is characterized by severe hypotonia, muscle weakness, and lactic acidosis in infants.
- Affected infants may spontaneously recover if they survive the initial months.
Observation:
- A 4-week-old girl presented with hyperammonemia, hypotonia, and failure to thrive.
- Genetic evaluation did not identify a distinct syndrome, and her condition worsened.
- Muscle biopsy revealed severe mitochondrial myopathy with COX-negative fibers and ultrastructural mitochondrial abnormalities.
Findings:
- Molecular studies identified a homoplasmic mutation (m.14674 T>C) in the MT-TE gene.
- This mutation is associated with reversible cytochrome c oxidase (COX) deficiency.
- Hyperammonemia, though unusual, was a presenting symptom.
Implications:
- Hyperammonemia should be considered in the differential diagnosis of infants with suspected reversible infantile respiratory chain deficiency.
- This case highlights the importance of comprehensive evaluation, including muscle biopsy and molecular studies, for diagnosing rare mitochondrial disorders.
- Early identification and understanding of presenting symptoms can guide clinical management and improve outcomes for affected infants.
Abstract:
Reversible infantile respiratory chain deficiency, previously termed reversible infantile cytochrome c oxidase (COX) deficiency myopathy, is a rare mitochondrial disorder that is characterized by severe hypotonia and generalized muscle weakness in infancy that is associated with lactic acidosis. Affected infants will spontaneously recover, if they survive the first months of life. Here, we present the case of a 4-week-old girl who initially presented with hyperammonemia, hypotonia, and failure to thrive, for which she was referred for genetic evaluation. After several tests, a distinct genetic syndrome could not be identified and she continued to deteriorate. A muscle biopsy was performed and demonstrated severe mitochondrial myopathy with abundant COX-negative fibers. Ultrastructural abnormalities of the mitochondria, diagnostic of mitochondrial myopathy, were identified on electron microscopy. Molecular studies revealed the classic homoplasmic disease causing mutation, m.14674 T>C in the MT-TE gene, associated with reversible COX deficiency. Although hyperammonemia is an unusual presentation for mitochondrial myopathies, specifically reversible infantile respiratory chain deficiency, it should be included in the list of possible presenting symptoms for this condition.
More Related Videos
11:25Hybrid Clear/Blue Native Electrophoresis for the Separation and Analysis of Mitochondrial Respiratory Chain Supercomplexes
Published on: May 19, 2019
08:07Analysis of the Expression and Complexes Assembly of the Mitochondrial Respiratory Chain Proteins in the Fission Yeast Schizosaccharomyces pombe
Published on: May 2, 2025
Related Concept Videos
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
Acute Respiratory Failure-IV
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...